Spectrum Pharmaceuticals Inc

VANGUARD GROUP INC

Report date

6/30/2023

Quarter

2023 Q2

Filed

8/14/2023

Shares

8,580,357

Value ($000)

8,237

Weight

0.0%

2013 Q4 - 2023 Q2 (18 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q2	8/14/2023	8,237	0.0%	8,580,357	6/30/2023
2023 Q1	7/14/2023	6,583	0.0%	8,777,670	3/31/2023
2022 Q4	2/10/2023	3,096	0.0%	8,400,287	12/31/2022
2022 Q3	11/14/2022	3,727	0.0%	8,667,120	9/30/2022
2022 Q2	8/12/2022	6,886	0.0%	8,828,676	6/30/2022
2022 Q1	5/13/2022	10,273	0.0%	7,963,782	3/31/2022
2021 Q4	2/14/2022	12,055	0.0%	9,492,321	12/31/2021
2021 Q3	11/12/2021	23,373	0.0%	10,721,177	9/30/2021
2021 Q2	8/13/2021	50,041	0.0%	13,344,285	6/30/2021
2021 Q1	5/14/2021	41,161	0.0%	12,626,136	3/31/2021
2020 Q4	2/12/2021	41,256	0.0%	12,098,371	12/31/2020
2020 Q3	11/16/2020	46,907	0.0%	11,496,751	9/30/2020
2020 Q2	8/14/2020	40,970	0.0%	12,121,314	6/30/2020
2020 Q1	5/15/2020	30,916	0.0%	13,268,542	3/31/2020
2019 Q4	2/14/2020	49,345	0.0%	13,556,091	12/31/2019
2014 Q2	8/11/2014	30,453	0.0%	3,745,639	6/30/2014
2014 Q1	5/13/2014	29,106	0.0%	3,712,514	3/31/2014
2013 Q4	2/12/2014	32,191	0.0%	3,637,429	12/31/2013